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Gelation properties of self-assembling N-acyl 
modified cytidine derivatives 
K. J. Skilling, a A. Ndungu, a B. Kellam, a  M. Ashford, b T. D. Bradshaw, a and M. 
Marlow a  
In this study we report the synthesis of new cytidine derived gelators possessing acyl chains of 
different lengths. These low molecular weight gelators were shown to form self-supporting 
gels at 0.5 % (w/v) in binary systems of aqueous miscible polar organic solvent and water. The 
representative gels were studied using rheology and their fibrillar structure confirmed by TEM 
imaging and FTIR. We further demonstrated the use of these gels as potential drug delivery 
platforms by monitoring release characteristics of both high and low molecular weight 
fluorescently labelled tracers.  
 
 
 
Introduction  
Progress in the field of low molecular weight gelators 
(LMWGs) is motivated by the numerous potential industrial 
and medical applications. Their attractive self-assembling 
properties and associated mechanical properties make them 
ideal for use in cosmetics, medicines and foods.  
The self-assembled 3D fibrillar network of a LMWG is 
stabilised by non-covalent molecular interactions; hydrogen 
bonding, π-π stacking, hydrophobic forces and electrostatic 
interactions. These interactions make LMWGs particularly 
advantageous for drug delivery as they will gelate under mild 
conditions such as subtle changes in pH or solvent polarity. 
Many examples of chemical entities which form low molecular 
weight gels by these processes exist 1, 2 of which di and tri 
peptide amphiphiles 3-5 are most common, however, reports of 
gelators that are both biocompatible and applicable in the field 
of drug delivery are rare. 6  
Nucleoside derived LMWGs have received little interest for the 
specific purpose of drug delivery, however, the abundance of 
nucleosides in nature makes them inherently biocompatible and 
thus an ideal foundation for a drug delivery platform. 
Additionally, nucleosides contain specific functional groups 
that make them particularly suited to becoming LMWGs; the 
nucleobase forming intermolecular interactions in a 
perpendicular direction whilst hydrogen bonding and π-π 
stacking brought about from the heterocyclic ring holds 
together higher order structures.  
Moreover, there is already a literature precedent for using 
nucleosides as the foundation for LMWGs, where previous 
studies have reported modified nucleosides that gelate in water. 
7 For many years it has been know that guanosine makes a good 
hydrogelator in a K+ dependent system. 8 More recent findings 
suggest that a similar K+ deoxy-guanosine system forms much 
better gels with improved thixotropic properties compared to 
the guanosine counterparts. 9 Other gelators arise via 
modification of the ribose sugar, a strategy employed by Yun, 
10 Godeau 11 and Moreau 12 and Xu 13, 14 who recently reported 
enzyme labile gelating structures derived from existing known 
peptide gelators, functionalised at the 5’-position of the 
nucleoside guanosine and the nucleobase uridine. Another route 
less often taken is modification of the nucleobase at the 5-
position, an example of which is that taken by Park 15 to 
derivatise ribo- and deoxyuridine.  
The chemical modification of cytidine (Figure 1a) is less 
commonly reported; one of the earliest reports of cytidine 
derived gelators was of 5-triazoldeoxycytidines however the 
report was brief and didn’t contain any information regarding 
gelation procedures. 16 More recently azide modified cytidine 
derivatives were synthesised 17 and were found to gel at 
minimal concentrations of 0.3 % (w/v) however there are no 
other reported cytidine derived gelators. 
Herein we report a new series of modified cytidine LMWGs 
derived by functionalisation with an acyl chain at the 4-N-
position of the cytosine ring; we explore how a co-solvent 
volume fraction of either DMSO or ethanol and water affects 
gel mechanical strength and nanostructure; and we demonstrate 
the capacity of these gels to act as reservoirs for drug like 
materials. 
Results and Discussion 
The nucleoside, cytidine, 1 consists of a hydrophilic sugar 
moiety and a cytosine nucleobase that we hypothesised would 
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possess the hydrogen bonding donor and acceptor groups 
necessary to create the one dimensional order required to 
initiate gelation. 1 Introduction of hydrophobicity i.e. with an 
acyl chain would generate the solvophobic forces also required 
for gelation. By adapting previous literature 18 used to 
synthesise other nucleoside conjugates we were able to 
selectively acylate the N-position of the nucleobase using a 
series of fatty acids via a simple one-pot procedure (Figure 1b) 
generating compounds 2-5. The formation of an activated 
triazine ester favours the addition on the N-position over the 
less nucleophilic 5’-position. Each of these compounds was 
synthesised with a yield of 39 – 60 % and with > 95 % purity 
via RP-HPLC.  
 
 
 
Figure 1: a) Structure of Cytidine and b) Reagents and conditions i. n-
methylmorpholine, CH2Cl2, 0 oC, 1 h; ii. Fatty acid, 0 oC, 2 h, iii. Cytidine, DMF, 
50oC, 12-24h.  
 
None of the conjugates 2-5 were found to dissolve in water 
directly thus, gelation tests were conducted using a binary 
mixture of aqueous miscible organic solvent (dimethylsulfoxide 
(DMSO) 19 or ethanol) and water.  
DMSO is currently the most common solvent used to solubilise 
gelators prior to gelation and is usually used sparingly, due to 
toxicity levels. However, for a cancer drug delivery platform 
increased concentrations of DMSO are potentially 
advantageous. DMSO has been shown to reduce growth of a 
human ovarian carcinoma (HOC-7) cell line reversibly in a 
dose- and time dependent manner 20 and to reduce the 
tumourigenicity of human pancreatic cell lines. 21 Conversely, 
few papers exist that claim to use ethanol as a gelating medium. 
A rare, recent example uses a gel formulated with 40 % (v/v) 
ethanol to demonstrate the enhanced release profile of 
indomethacin. 22 Additionally, ethanol has a been used 
extensively as a pharmaceutical co-solvent for solubilisation of 
poorly soluble drugs, 23 and has associated clinical guidance 
recommending intra-tumoural ethanol injection in oesophageal, 
gastric and pancreatic tumours as a method of ablation. 24 
Hence, we believe ethanol would enhance the therapeutic effect 
of a localised, targeted drug delivery system.  
LMWGs are commonly formed by using a low percentage (0.1 
– 5 % (w/v)) of gelator molecule in an appropriate medium. In 
recent times an increased understanding in the way LMWGs 
should be designed means molecular properties can be tailored 
so that gels can be consistently formed at concentrations 
towards the lower limit of the accepted range. Many examples 
of gelators that assemble in a low concentration range (0.02 – 
0.5 % (w/v)) exist. 1 Here, we report the gelation of conjugates 
2-5 in different solvent volume fractions (ΦSOL) (0.05 to 0.50) 
and with a low final compound concentration of 0.5 % (w/v). 
The qualitative stability of the gels was analysed by ‘stable to 
inversion’ assessment of the container, resulting from gels 
prepared via a heating-cooling method; when the liquid no 
longer flowed it was concluded that gelation had occurred. 
(Figure S2, ESI†)  
As reported elsewhere for dipeptides, 25, 26 the addition of water 
to the gelator containing organic phase results in the appearance 
of a turbid solution that gradually, over time clarifies to give a 
stable gelator. This too was noticed for our N-acyl nucleoside 
series 2-5 (Table 1). It is hypothesised that this may be due to 
restructuring of an initial self-assembled structure from many 
irregular aggregates into more highly ordered structures. 25 It 
was noticed that the more lipophilic character the nucleoside 
conjugate possessed the less stable the gels were to inversion. 
This was particularly apparent in gels of 4 and 5 where across 
both DMSO and ethanol series’ only one visually stable gelator 
was seen at ΦEtOH 0.40 and ΦDMSO 0.50, respectively. 
No gelation was seen at low solvent volume fractions of 0.05 in 
any conjugates though the presence of weak gels became 
apparent at ΦSOL 0.10 in gels of 2 and 3. However, an increased 
turbidity was seen in these samples, this was particularly 
apparent in those gels containing 2, where clarification didn’t 
seem to happen even at ΦSOL 0.50. In gels of 3 a visually stable 
clarified sample occurred at ΦSOL 0.40. Additional stability to 
inversion was noted for samples of 3 prepared in ethanol over 
their DMSO counterparts. This observation may be attributed to 
the disruption in hydrogen bonding caused by DMSO. We have 
shown here that by creating a binary mixture of solvent (DMSO 
or ethanol) and water, we could reproducibly promote gelation 
and have demonstrated an increased propensity for gelation of 
conjugate 3 in organic solvent/water when compared to series 
2, 4 and 5.  
Table 1: Representative data table for Gels of 2-5 in DMSO and ethanol with solvent 
volume fractions (ΦSOL) from 0.05 to 0.50 and with final compound concentrations of 
0.5 % (w/v) where G: Gel; WG: Weak Gel P: Precipitate  
 
To further understand the stability of the gel to inversion, 
samples made with 0.5 % (w/v) conjugate 3 (cytidine-N-
myristoyl) were analysed by oscillatory rheology to quantify 
the mechanical strength of each gel and to identify the optimum 
solvent ratio. The viscoelastic properties of the gels were found 
 Conjugate 
 ΦSOL 
DMSO ethanol 
2 3 4 5 2 3 4 5 
0.05 P P P P P P P P 
0.10 WG P P P WG WG P P 
0.20 WG WG WG WG WG WG WG WG 
0.30 WG WG WG WG G G WG WG 
0.40 WG G WG WG WG G G WG 
0.50 G G WG G WG G WG WG 
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to depend upon the ΦSOL in the system (Figure 2) a feature that 
has been reported previously for dipeptide hydrogels, of 
concentrations up to Φ DMSO 0.40. 25 Here we found a very good 
correlation between visual stability and the associated 
quantitative mechanical strengths. We noted that above ΦSOL 
0.50 the sample behaves more like a liquid owing to the 
solubility of the compound in organic solvent. The storage 
modulus (G’) of the gels generally increased with increasing 
solvent fraction up to ΦSOL 0.40 giving a maximum of 3500 Pa. 
The mechanical properties (G’ and G’’) of the gels were 
reproducible (means and standard deviations are of 3 
independent samples). In every case the G’ exceeded G’’ by at 
least an order of magnitude; a feature significant amongst low 
molecular weight gelators. 27 Values of G’ and G’’ of ΦEtOH 
0.40 were found not to be dependent on oscillatory frequency 
between 1 and 100 rad/s, an indicator of a strong cross-linked 
fibrillar structure. However, a frequency dependency was seen 
for the corresponding ΦDMSO 0.40 sample indicating a weaker 
intermolecular network.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: G’ values of 3 (0.5 % (w/v)) in DMSO (black square) and ethanol (blue 
circle) at 1 % strain i.e. in the linear viscoelastic region. All measurements were 
carried out in triplicate and the mean calculated. Error bars represent standard 
deviation.  
 
To investigate further the above oscillatory rheology data, we 
probed the molecular interactions by FTIR. (Figure 3c) IR 
peaks at 1681 and 1642 cm-1 represent the amide I region of 3. 
28 As the volume fraction of solvent was increased from ΦEtOH 
0.20 to 0.30 a clear change in the molecular packing was 
observed. The peak at 1681 was seen to broaden and attenuate, 
shifting slightly from 1681 cm-1 to 1678 cm-1. An additional 
shift was seen from the peak at 1652 cm-1 shifting and 
broadening into a peak at 1642 cm-1. The peak shifts and 
broadening observed via FTIR are indicative of hydrogen 
bonding and have been observed for other gelating 
molecules.15, 29 These findings imply the change from ‘free’ 
single molecules to a hydrogen bonded network. 
This hydrogen bonded network is characteristic of a cross-
linked LMWG, a feature that was further supported by scanning  
electron microscopy (SEM) and transmission electron 
microscopy (TEM). (Figure 3a, b) At a fraction ΦEtOH 0.40 we 
saw cross-linked fibrillar structures, again a structural feature of 
a LMW gelating network. The fibre diameters were in the 
region of 15-25 nm with a length of up to 100’s microns.  
Further observations of the TEM imaging suggested that the 
fibrillar networks contained a number of microscopic cavities, 
which could potentially be used for encapsulation and 
controlled drug release. However due to sample preparation and 
the high vacuum drying conditions involved we can’t assume 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: a) SEM and b) TEM image of 3 (ΦEtOH 0.40) with a sample vial inversion 
and c) FTIR top to bottom ΦEtOH 0.50, 0.40, 0.30 and 0.20. Spectra are off set to 
demonstrate peak shifts and peak broadening.    
 
that these features are completely representative of the matrix 
in its hydrated state. To examine the above observation we 
examined the gel matrix using a series of in-vitro release 
studies. The gels of 3 (ΦEtOH 0.40) were self-assembled in the 
presence of large and small molecular weight fluorescent 
molecules. The lowest molecular weight fluorescent molecule 
was fluorescein, possessing a molecular mass of 332 Da, the 
second, a higher molecular mass fluorescent, fluorescein 
isothiocyanate (FITC)-Dextran with a molecular mass of 4 kDa 
and the final FITC Dextran 10 (10 kDa). A quantity (5 mL) of 
buffer was introduced to the top of the gel and aliquots (150 
μL) removed from the buffer at intervals (1, 8 and 24 h) and we 
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were then able to measure the fluorescence and calculate the 
percentage of molecules released. (Figure 4) 
Our studies demonstrated that 88 % of fluorescein molecules 
are released within 24 h from the gel matrix, FITC Dextran 4 
showed a moderate 66 % release whilst the larger FITC-
Dextran 10 molecules demonstrated very little release during 
the same time frame. This could be attributed to the close 
packing of the fibres within the gel matrix significantly 
retarding the free diffusion of these larger molecules. We can 
therefore assume that the gel will retain molecules with a large 
mass and molecules with smaller masses (100’s Da) will be 
released in agreement with others who have also shown similar 
retention of higher molecular mass molecules from a gelating 
dipeptide based hydrogel.4, 30. Such properties suggest potential 
applications in drug delivery for example as a depot for intra-
tumoural drug release.  
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Figure 4: Percentage release of Fluorescein (0.15 mM), FITC Dextran 4 (0.06 mM) 
and FITC Dextran 10 (0.01 mM) through the gel matrix. This figure is 
representative of 5 repeat release experiments, n = 4 in each experiment.  
 
To demonstrate the biocompatibility and applicability of these 
cytidine-N-myristoyl conjugates as the foundation of an intra-
tumoural drug delivery platform, the in-vitro toxicity was 
examined via mammalian cell growth inhibition assays and the 
concentration inhibiting growth by 50 % (GI50) determined. 
The conjugate 3 was incubated with human breast (MCF-7) and 
colorectal (HCT-116) carcinoma cells for 72 h at 37 oC. The 
results (Figure 5) suggest a comparable toxicity between our 
conjugates and the parent compound cytidine in both cell lines 
with the conjugate demonstrating GI50 values of 6.37 mM and 
7.78 mM respectively.  
 
Experimental Section 
Materials 
All chemicals and solvents were purchased from commercial 
suppliers and used without further purification. Synthetic 
reactions were performed in oven-dried glassware and 
magnetically stirred. Thin layer chromatography (TLC) was  
 
Figure 5: Growth Inhibition data on a) MCF-7 cells and b) HCT-116. T0 represents 
100 % growth inhibition.  
 
performed on Merck Kieselgel 60 F254 plates. All compounds 
were visualized either by UV light source (254 nm) or by 
staining in potassium permanganate solution. Silica column 
chromatography was carried out using silica gel, Merck 
Kieselgel 60, 230-400 mesh (Merck KgaA, Darmstadt, 
Germany). 
Methods 
General Methods 1H NMR spectra were recorded on a Bruker 
400 Ultrashield at 400 MHz at 25 oC. 13C NMR spectra were 
recorded on a Bruker 400 Ultrashield at 100 MHz at 25 oC. 
Solvent used for NMR analysis was DMSO-d6 ((CHD2)2SO at 
δH 2.50 ppm, (CD3)2SO at 39.52 ppm). Chemical shifts (δ) are 
recorded in parts per million (ppm). Coupling constants (J) are 
recorded in Hz (rounded to one decimal place) and any 
significant multiplicities described by singlet (s), doublet (d),  
riplet (t), quadruplet (q) and multiplet (m). Spectra were 
assigned using COSY and HSQC sequences. High resolution 
mass spectra (HRMS) – time of flight electrospray (TOF ES +/-
) were recorded on a Waters 2795 separation module 
micromass LCT platform. Infrared spectra were obtained using 
Nicolet Fourier-transformed infra-red (FTIR) 
spectrophotometer. Reverse phase high performance liquid 
chromatography (RP-HPLC) was performed using a Waters 
2767 sample manager, Waters 2525 binary gradient module and 
visualised at 254 nm with a Waters 2487 dual wavelength 
absorbance detector. Spectra were analysed using MassLynx. 
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Analytical RP-HPLC was performed using a YMC-Pack C8 
column (150 mm x 4.6 mm x 5 µm) at a flow rate of 1 mL/min. 
The retention time (tR) of the final product is reported using an 
analytical method of 0 – 1 min 5 % solvent B in solvent A, 2 – 
26 min gradient of 5 % to 90 % solvent B in solvent A, 27 – 35 
min held at 90 % solvent B in solvent A, 35 - 36 min 90 % to 5 
% solvent B in solvent A, 36 - 38 min held at 5 % solvent B in 
solvent A (solvent A = 0.05 % TFA in H2O, solvent B = 0.05 % 
TFA in 9:1 v:v CH3CN:H2O).  
 
 Synthesis of N-acyl cytidine derivative, 3 To a solution of 
2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT, 20 mmol, 3.50 
g) in anhydrous CH2Cl2 (60 mL) at 0 oC, N-methylmorpholine 
(NMM, 27.2 mmol, 2.75 g) was added with continuous stirring 
until a white suspension had formed. The mixture was then left 
to stir for 1 h. Myristic acid (20 mmol) was added directly into 
the mixture as a solution in anhydrous DMF (20 mL) and 
stirred for a further hour. A solution of cytidine (20 mmol, 4.86 
g) in anhydrous DMF (20 mL) was made up at 0 oC. The cold 
triazine solution was added drop wise to the cooled cytidine 
solution over 30 mins, before heating to 50 oC and stirring for 
14 - 24 h. The cooled solution was evaporated in vacuo before 
adding water and triturating to remove excess CDMT, NMM 
and cytidine.  This was followed by trituration with CH2Cl2 to 
remove any excess myristic acid. The products were purified 
using flash silica column chromatography, eluting at 5 - 7 % 
methanol in CH2Cl2.  
 
3 1H NMR (DMSO-d6, 400 MHz) δ 0.85 (t, J = 7.2 Hz, 3H, 
CH3), 1.24 (s, 20H, CH2-(CH2)10-CH3), 1.53 (m. 2H, C=O-CH2- 
CH2), 2.38 (t, J = 7.3 Hz, 2H, C= -CH2), 3.56 - 3.61 (m, 1H, 
CH2-OH), 3.71 – 3.76 (m, 1H, CH2-OH), 3.89 – 3.90 (m, 1H, 
CH-CH2-OH), 3.93 – 3.98 (m, 2H, 2(CH-OH)), 5.03 (d, J = 5.7 
Hz, 1H, N-CH--CH-CH-OH), 5.14 (t, J = 5.1 Hz, 1H, CH2-
OH), 5.46 (d, J = 5.1 Hz, 1H, N-CH-CH-OH), 7.20 (d, J = 7.5 
Hz, 1H, N-CH-CH-C), 8.40 (d, J = 7.6 Hz, 1H, N-CH-CH-C), 
10.83 (s, 1H, NH).13C NMR (DMSO-d6, 100 MHz) δ 13.92, 
22.06, 24.4, 28.42, 28.67, 28.83, 28.98, 29.02, 31.26, 36.33, 
59.91, 68.65, 74.51, 84.18, 90.13, 95.20, 145.31, 154.66, 
162.30, 173.92. HRMS calculated for C23H40N3O6+ 454.2192 
(M+H)+; found 454.2928. Analytical RP-HPLC tR = 23.9 min, 
Yield: 46.0 %, 99.7 % purity. 
 
 Preparation of Gels In all cases, gels of each amphiphilic 
conjugate were prepared as follows; 2 - 5 were weighed using 
an A and D GR-202 semi micro-analytical balance into 1.5 ml 
sample vials. Solvent (DMSO or ethanol, 1 mL) was added to 
create stock solutions at 10 % (w/v) This solution was then 
sonicated in a Sonicor Ultra- sonic bath for 1 - 2 minutes before 
heating to 60 oC to dissolve the compound fully. A small 
aliquot (25 μL) of this stock solution was transferred to another 
1.5 mL heated vial before adding additional solvent and finally 
pre heated (60 oC) ultra-purified water. The sample was then 
left to cool down to room temperature in the heating plate and 
left standing for 18 h. 
 
 Fourier Transformed Infrared Spectroscopy (FTIR) IR 
spectra were collected using an Agilent Cary 630 spectrometer 
with ATR crystal at 8 cm-1 resolution, averaging over 32 scans 
from 4000 cm-1 to 650 cm-1. The gels of 3 (0.5 % (w/v)) used 
for IR measurements were prepared in a mixture of EtOD-d6 
and D2O as described above. After being allowed to gel 
overnight, samples were placed onto an ATR crystal and 
scanned.  
 
 Rheology Rheology experiments were carried out using an 
Anton Paar MCR302 Modular Compact Rheometer. A four-
bladed vane geometry was used with a diameter of 8.5 mm and 
length 8.5 mm in a cup with a diameter of 14.5 mm. For the 
strain and frequency measurements the solution of gelator was 
prepared in a 7 mL sterilin plastic sample vial and gelation 
promoted in the same manner as in the standard gelation 
procedure described above (to make a volume of 2 mL). Once 
the gel had been prepared, the sample vial was mounted in the 
lower plate (cup) of the rheometer, the vane (attached to the 
upper part) was lowered into place. This arrangement gave a 
sample depth of approximately 16 mm in the 14.5 mm diameter 
cup which allowed positioning of the vane in the centre of the 
sample.31 All strain amplitude measurements were made within 
the linear viscoelastic region of the gel sample where the 
storage modulus and loss modulus (G’ and G’’ respectively) are 
independent of the strain amplitude. The G’ and G’’ were 
measured at a frequency of 10 rad s-1. Frequency scans were 
executed from 1 rad s-1 to 100 rad s-1 under a strain of 1 %.  
 
 Transmission Electron Microscopy (TEM Imaging) The 
morphology of the self-assembled fibres was assessed using a 
JEOL JEM 2100 transmission electron microscope (TEM). To 
prepare samples, a small amount of gel was dispersed in 200 μL 
of ultra-purified water and pipetted on to a carbon-coated 
copper grid (No. 400). Excess sample was blotted with 
Whatman 50 filter paper. The grid was subjected to high 
vacuum prior to inserting into the machine and imaging at an 
accelerated voltage of 200 kV.  
 
 Growth Inhibition Studies Cells were seeded at a density 
of 3 x 103 per well into 96-well microtiter plates and allowed to 
adhere for 24 h before test agent was introduced (0.1 nM – 100 
M, n = 8). Serial dilutions were prepared in RPMI medium 
prior to each assay.  At the time of agent addition and following 
72 h exposure, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) was added to each well 
(final concentration 400 μg/mL). Incubation at 37 oC for 3 h 
allowed reduction of MTT by viable cells (mitochondrial 
dehydrogenases) to insoluble formazan crystals. Well 
supernatants were removed, and intracellular formazan 
solubilized by addition of DMSO (150 μL). Absorbance was 
read at 550 nm using a Perkin Elmer plate reader. Non-linear 
regression analysis was used to calculate compound 
concentrations required to inhibit 50 % of cell growth (GI50).  
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 In-vitro release kinetics Gels (ΦEtOH 0.40) containing 
fluorescent dyes were prepared in 7 mL sterilin cups up to the 
volume of 2 mL with the dye phase replacing the aqueous 
phase in each instance. Stock solutions of each dye were 
prepared so that the fluorescent output would be within the 
linear region of the calibration curves (0.15 mM Fluorescein 
and 0.06 mM Fluorescein isothiocyanate (FITC) Dextran 4 kDa 
and 0.1 mM FITC Dextran 10 kDa). Having prepared the gels 
using the standard method, the gel volume was allowed to stand 
for 18 h to allow time for complete gelation. Ultra-purified 
water (5 mL) was gently placed on top of each gel and the 
initial time point taken (150 μL, T0), subsequent readings (150 
μL) were taken at further time points and the fluorescence 
measured (excitation of 485 nm with the emission measured at 
521 nm) using a Perkin Elmer plate reader 
Conclusions 
We have designed a novel series of low molecular weight 
nucleoside gelators derived via simple chemical modification of 
the N-position on the cytosine nucleobase and have shown how, 
when prompted by a change in solvent polarity, we observe a 
rapid gelation process resulting in the formation of a stable self-
assembled cross-linked fibrillar network.  
Through rheological testing, TEM imaging and FTIR we have 
demonstrated the importance of the solvent: water ratio to the 
self-assembly process. Specifically we have shown that a gel 
containing ΦEtOH 0.40 displays enhanced self-assembly 
capabilities, arranging itself into an ordered highly cross-linked 
fibrillar structure with an increased mechanical strength. FTIR 
spectroscopy alluded to the critical importance of the amide 
functionality in the self-assembly process. Additionally, the 
possible application of such gels as reservoirs for both large and 
small bio macromolecular therapeutics was fully demonstrated. 
Furthermore, we proposed how this increased solvent ratio 
could be advantageous particularly for delivery of cancer 
therapeutics but may also hold additional applications for 
example in the field of dermatology. We therefore propose 
these cytidine gelators as useful chemical building blocks for 
new gelators in drug delivery.   
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